MENU

Sujana Movva, MD

Sujana Movva, MD

Clinical Locations

Primary Location

Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111

About

Assistant Professor, Department of Hematology/Oncology

TRDG Member, Brain CancerMelanoma and Skin CancerSarcoma and GIST Cancer

NCCN, Bone Cancer Panel Member

Treatment Focus

Sarcoma & Melanoma

Research Program

Treatment Philosophy

I decided to join Fox Chase Cancer Center because of the expertise in the field of sarcoma and the institution’s dedication to cancer care. I continue to be impressed by the passion toward this mission exhibited by every employee here.

Patients with sarcomas are usually otherwise healthy and young; therefore, I think that it is of utmost importance to find new drugs for this disease. My interest in clinical research includes finding new agents for patients with sarcoma and melanoma and trying to figure out why certain patients respond to treatments and others do not.

A cancer diagnosis is a life changing event. I think it is important for patients to feel confident in the care they are receiving. I hope that my patients always feel that they are important and that the relationship allows them to maintain hope and control during this time in their life.

Education and Training

Educational Background

  • Fellow, Hematology/Oncology, University of New Mexico, Albuquerque, NM, 2007-2010
  • Resident, Internal Medicine, Michigan State University, McLaren Regional Medical Center, Flint, MI, 2004-2007
  • MD, University of Western Ontario, London, Canada, 2003

Certifications

  • American Board of Internal Medicine
  • Board Certified in Medical Oncology

Memberships

  • National Comprehensive Cancer Network (NCCN)
    • Bone Cancer Panel
  • American Society of Clinical Oncology
  • Connective Tissue Oncology Society
Patient Stories

Victoria Mirarchi

Sarcoma

Victoria Mirarchi

Sarcoma

At 81 years old, Victoria Mirarchi was still active and healthy before undergoing surgery at a local hospital to remove a large mass from her abdominal area. The mass was diagnosed as liposarcoma, an aggressive tumor. When the tumor returned twice, Victoria decided to seek a second opinion from the specialists at Fox Chase Cancer Center. Following the surgery at Fox Chase, Victoria is happy to report that the cancer has not returned. She said, "I am so happy everything went well, and I still go back to Fox Chase every few months to see Dr. Reddy. I wish nothing but the best for all the surgeons there, and keep them in my prayers daily."

Sister Marcille McEntee

Skin Cancer;  Ureteral Cancer

Sister Marcille McEntee

Skin Cancer;  Ureteral Cancer

Sister Marcille McEntee is no stranger to miracles.  As a Sister, and Servant of the Immaculate Heart of Mary, her faith is deep and abiding.  Yet to see a miracle at work in her own life is still a special blessing.  

Jean Hankee

Sarcoma

Jean Hankee

Sarcoma

In 2011, Jean Hankee noticed a strange-looking vein on her right shin. At first, she said it looked like an “empty" varicose vein. “I thought it was just something that happened as I was getting older,” said Jean, who was 71 at the time.

Abu-Methuselah Bradley

Sarcoma

Abu-Methuselah Bradley

Sarcoma

I was 39 years old, married, the father of two children, a pharmaceutical sales representative, and part-time church pastor when I was diagnosed with cancer in 2013. I felt like the epitome of health at 6’4” tall and a trim 208 pounds, since I was athletic and enjoyed bike riding, running, and other outdoor activities.

Carla Rake

Melanoma;  Skin Cancer

Carla Rake

Melanoma;  Skin Cancer

My family has become a ‘sun-smart’ family since I was diagnosed and treated for melanoma. We wear hats, seek the shade, and use sun block. That’s a big change since the days when I would go to the tanning salon as often as three times a week and take vacations at tropical and beach locations to maintain my tan.

Pages

Research Profile

Research Program

Research Interests

  • Drug development
  • Biomarkers
  • Sarcoma
Publications

Selected Publications

Moten AS, Movva S, von Mehren M, Wu H, Esnaola NF, Reddy SS, Farma JM. Granular cell tumor experience at a comprehensive cancer center. J Surg Res, 226:1-7, 2018. PubMed

Movva S, von Mehren M, Ross EA, Handorf E. Patterns of chemotherapy administration in high risk soft tissue sarcoma and impact on overall survival. (JNCCN) Journal of the National Comprehensive Cancer Network, Vol. 13, Number 11, November, 2015.

Norberg SM, Movva S. Role of genetic and molecular profiling in sarcomas. Curr Treat Options Oncol. 2015 May;16(5):339. doi: 10.1007/s11864-015-0339-3. PubMed

Movva S, Wen W, Chen W, Millis SZ, Gatalica Z, Reddy S, von Mehren M, Van Tine BA. Multi-platform profiling of over 2000 sarcomas: Identification of biomarkers and novel therapeutic targets. Oncotarget. 2015 Mar 26. [Epub ahead of print] PubMed

Verschraegen CF, Movva S, Ji Y, Schmit B, Quinn RH, Liem B, Bocklage T, Shaheen M. A phase I study of the combination of temsirolimus with irinotecan for metastatic sarcoma. Cancers (Basel). 2013 Apr 11;5(2):418-29. doi: 10.3390/cancers5020418. PubMed

Cardona K, Movva S. Issues in the management of high-risk localized sarcomas. Curr Probl Cancer. 2013 Mar-Apr;37(2):62-73. doi: 10.1016/j.currproblcancer.2013.03.002. PubMed

Cardona K, Williams R, Movva S. Multimodality therapy for advanced or metastatic sarcoma. Curr Probl Cancer. 2013 Mar-Apr;37(2):74-86. doi: 10.1016/j.currproblcancer.2013.03.003. Review. PubMed

Movva S. Emerging therapies for sarcoma. Curr Probl Cancer. 2013 Mar-Apr;37(2):87-101. doi: 10.1016/j.currproblcancer.2013.03.004. Review. PubMed

Verschraegen CF, Arias-Pulido H, Lee SJ, Movva S, Cerilli LA, Eberhardt S, Schmit B, Quinn R, Muller CY, Rabinowitz I, Purdy M, Snyder D, Bocklage T. Phase IB study of the combination of docetaxel, gemcitabine, and bevacizumab in patients with advanced or recurrent soft tissue sarcoma: the Axtell regimen. Ann Oncol. 2012 Mar;23(3):785-90. doi: 10.1093/annonc/mdr299. Epub 2011 Jul 11. PubMed

Movva S, Verschraegen C. Systemic management strategies for metastatic soft tissue sarcoma. Drugs. 2011 Nov 12;71(16):2115-29. doi: 10.2165/11594500-000000000-00000. Review. PubMed

Movva S, Verschraegen CF, Rabinowitz I, Mangalik A, Parks V, Lee FC. Phase I dose finding study of carboplatin, paclitaxel, and temozolomide in advanced solid tumors. Melanoma Res. 2011 Feb;21(1):76-9. doi: 10.1097/CMR.0b013e32833d3293. PubMed

Movva S, Verschraegen C. The monoclonal antibody to cytotoxic T lymphocyte antigen 4, ipilimumab (MDX-010), a novel treatment strategy in cancer management. Expert Opin Biol Ther. 2009 Feb;9(2):231-41. doi: 10.1517/14712590802643347. Review. PubMed

 

Additional Publications

My NCBI 

Ratings

45 PATIENT SATISFACTION REVIEWS

Our Patient Satisfaction Rating is an average of all responses to care provider related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. Learn more.

OVERALL RATING

4.8 / 5.0

RATINGS BREAKDOWN

  • 4.7
  • 4.9
  • 4.8
  • 4.9
  • 4.8

3 PATIENT COMMENTS

  • 3.0
    April 15, 2018
    Dr. Mowa seems to be rushed these days. I've been with her over 3 years and it seems she is preoccupied and hurried at times (lately).
  • 5.0
    February 23, 2018
    Only saw Dr. Mowa twice, but kind, compassionate knowledgeable.
  • 5.0
    February 19, 2018
    Good experience.
LOAD MORE

Connect with Fox Chase